These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23082694)

  • 1. Risperidone-induced rabbit syndrome: an unusual movement disorder.
    Sansare K; Singh D; Khanna V; Karjodkar FR
    N Y State Dent J; 2012; 78(5):44-6. PubMed ID: 23082694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology.
    Schwartz M; Hocherman S
    CNS Drugs; 2004; 18(4):213-20. PubMed ID: 15015902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic.
    Levin T; Heresco-Levy U
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):137-9. PubMed ID: 10082239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit syndrome induced by combined lithium and risperidone.
    Mendhekar DN
    Can J Psychiatry; 2005 May; 50(6):369. PubMed ID: 15999955
    [No Abstract]   [Full Text] [Related]  

  • 5. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 6. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and treatment of rabbit syndrome, an uncommon complication of neuroleptic therapies.
    Todd R; Lippmann S; Manshadi M; Chang A
    Am J Psychiatry; 1983 Nov; 140(11):1519-20. PubMed ID: 6137964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Oral Vertical Dyskinesia ("Rabbit" Syndrome).
    Rissardo JP; Kherajani K; Vora NM; Yatakarla V; Fornari Caprara AL; Ratliff J; Caroff SN
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202628
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rabbit syndrome due to olanzapine].
    Sabolek M; Bayerle M
    Psychiatr Prax; 2005 May; 32(4):202-4. PubMed ID: 15852213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant.
    Singh R; Chakrabarti SS; Kaur U
    Daru; 2024 Jun; 32(1):439-441. PubMed ID: 37962835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rabbit syndrome: state of the art.
    Catena M; Fagiolini A; Consoli G; Ducci F; Carlini M; Picchetti M; Marazziti D
    Curr Clin Pharmacol; 2007 Sep; 2(3):212-6. PubMed ID: 18690867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.